Holdings
Great Point Partners LLC
As of Jun 30, 2026, Great Point Partners LLC reported 32 positions worth US$372M. Largest: Vor Biopharma Inc., Abivax Sa and Vera Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Vor Biopharma Inc. | 1.7M | US$31.3M | −50,000 | Jun 30, 2026 |
| Abivax Sa | 204K | US$27.2M | new | Jun 30, 2026 |
| Vera Therapeutics, Inc. | 601K | US$25.8M | +401K | Jun 30, 2026 |
| Zura Bio Limited | 4.22M | US$24.9M | no change | Jun 30, 2026 |
| Alumis Inc. | 856K | US$24.1M | no change | Jun 30, 2026 |
| Definium Therapeutics, Inc. | 425K | US$20M | new | Jun 30, 2026 |
| Annexon, Inc. | 3.5M | US$20M | +1M | Jun 30, 2026 |
| Oruka Therapeutics, Inc. | 183K | US$17.4M | no change | Jun 30, 2026 |
| Sagimet Biosciences Inc. - Series A | 2.03M | US$15.7M | new | Jun 30, 2026 |
| Contineum Therapeutics, Inc. | 921K | US$15.1M | +121K | Jun 30, 2026 |